Brown Advisory’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-752,575
| Closed | -$7.71M | – | 1371 |
|
|
2018
Q4 | $7.71M | Sell |
752,575
-375,728
| -33% | -$3.85M | 0.03% | 361 |
|
|
2018
Q3 | $18.8M | Buy |
1,128,303
+49,707
| +5% | +$828K | 0.05% | 259 |
|
|
2018
Q2 | $17M | Buy |
1,078,596
+12,432
| +1% | +$196K | 0.05% | 260 |
|
|
2018
Q1 | $13.5M | Buy |
1,066,164
+203,579
| +24% | +$2.59M | 0.04% | 271 |
|
|
2017
Q4 | $9.88M | Buy |
862,585
+289,120
| +50% | +$3.31M | 0.03% | 316 |
|
|
2017
Q3 | $7.03M | Buy |
573,465
+35,630
| +7% | +$436K | 0.02% | 346 |
|
|
2017
Q2 | $6.16M | Buy |
537,835
+12,707
| +2% | +$145K | 0.02% | 377 |
|
|
2017
Q1 | $10.9M | Buy |
525,128
+27,175
| +5% | +$565K | 0.04% | 280 |
|
|
2016
Q4 | $10.4M | Buy |
497,953
+38,041
| +8% | +$791K | 0.04% | 283 |
|
|
2016
Q3 | $15.1M | Buy |
459,912
+33,422
| +8% | +$1.1M | 0.05% | 239 |
|
|
2016
Q2 | $10.7M | Buy |
426,490
+45,816
| +12% | +$1.14M | 0.04% | 273 |
|
|
2016
Q1 | $9.32M | Buy |
380,674
+1,095
| +0.3% | +$26.8K | 0.03% | 281 |
|
|
2015
Q4 | $12.5M | Buy |
379,579
+206,108
| +119% | +$6.81M | 0.04% | 250 |
|
|
2015
Q3 | $5.68M | Buy |
173,471
+101,135
| +140% | +$3.31M | 0.02% | 342 |
|
|
2015
Q2 | $3.83M | Buy |
+72,336
| New | +$3.83M | 0.01% | 373 |
|